What conditions can cause a falsely low hemoglobin A1c in a patient with fasting plasma glucose 120‑130 mg/dL, and why is hemoglobin A1c still used for diabetes diagnosis despite such potential inaccuracies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Your Discordant A1C and Glucose Values

Your A1C of 4.1% is falsely low and does not reflect your true glycemic status, given your fasting glucose consistently measures 120-130 mg/dL—this discordance indicates a condition affecting red blood cell turnover or a hemoglobin variant is interfering with your A1C measurement. 1

Why Your A1C is Unreliable

Several conditions cause falsely low A1C values despite elevated glucose levels:

Conditions with Increased Red Blood Cell Turnover

These shorten the lifespan of red blood cells, preventing adequate glycation time:

  • Hemolytic anemias (any cause) 1
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency - can lower A1C by 0.7-0.8% in homozygous individuals 1
  • Recent blood loss or transfusion 1
  • Hemodialysis 1
  • Erythropoietin therapy 1
  • Pregnancy (second and third trimesters) 1
  • Beta-thalassemia minor - particularly when associated with increased red cell turnover 2, 3
  • Liver cirrhosis with associated hematologic changes 4

Hemoglobin Variants

These interfere with A1C measurement by the assay itself:

  • Sickle cell trait (HbS) - lowers A1C by approximately 0.3% 1
  • Rare hemoglobin variants (Hb Iraq-Halabja, Hb J-Bangkok, Hb Riyadh) - can cause spuriously low readings on standard HPLC assays 5, 3, 6
  • Hemoglobin C trait 1

Other Interfering Conditions

  • High-dose vitamin C or E supplementation - may inhibit glycation 1
  • Certain medications affecting red cell turnover 7

What You Should Do Next

Immediate Diagnostic Steps

  1. Request a complete blood count (CBC) with reticulocyte count to assess for hemolytic anemia or increased red cell turnover 2, 3

  2. Check hemoglobin electrophoresis to identify hemoglobin variants that may be interfering with your A1C assay 1, 3

  3. Consider G6PD testing if you have African, Mediterranean, or Asian ancestry 1

  4. Measure glycated albumin or fructosamine as alternative glycemic markers unaffected by red cell turnover 2, 3

  5. Review your A1C chromatogram - abnormal peaks suggest hemoglobin variants 3

For Ongoing Monitoring

Use fasting plasma glucose and postprandial glucose measurements exclusively for diabetes diagnosis and monitoring in your case, as the American Diabetes Association explicitly recommends plasma glucose criteria when A1C is unreliable. 1

Your fasting glucose of 120-130 mg/dL places you in the prediabetes range (100-125 mg/dL is prediabetes; ≥126 mg/dL on two occasions confirms diabetes). 1

Why A1C is Still Used Despite These Limitations

A1C remains the standard because:

  • Greater convenience - no fasting required 1
  • Better pre-analytical stability - less affected by acute stress or illness 1
  • Strong correlation with microvascular complications in most patients 1
  • Reflects 2-3 month average rather than single time point 1
  • Standardized assays (NGSP-certified) provide reliable results in 99% of patients without interfering conditions 1

However, the guidelines are clear: when marked discrepancies exist between A1C and plasma glucose levels, the A1C assay should not be considered reliable for that individual, and glucose-based criteria must be used exclusively. 1

Critical Clinical Pitfalls to Avoid

  • Do not rely on A1C alone when it conflicts dramatically with glucose measurements—your situation is a textbook example of when A1C fails 1
  • Do not assume normal A1C means normal glucose control in the presence of conditions affecting red cell turnover 2, 3, 4
  • Do not use point-of-care A1C devices for diagnosis—only laboratory NGSP-certified assays are acceptable, and even these fail in your situation 1, 8
  • Do not delay investigation of extremely low A1C (<4.0%) as it may indicate underlying hematologic or liver disease requiring attention 4

Your endocrinologist correctly identified this discordance. The next step is determining which specific condition is causing your falsely low A1C through the diagnostic workup outlined above.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Markedly low hemoglobin A1c in a patient with an unusual presentation of beta-thalassemia minor.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Research

[An abnormal hemoglobin which was found by chance at a health checkup].

Rinsho byori. The Japanese journal of clinical pathology, 1995

Guideline

Managing Elevated A1C Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fasting Glucose in Diabetes Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the implications of a low Hemoglobin A1c (HbA1c) level of 4.6?
What is the management approach for a patient with elevated Hemoglobin A1c (HbA1c) and suspected endocrine insufficiency?
Does thalassemia (beta-thalassemia) affect Hemoglobin A1c (HbA1c) results?
What is the accuracy of Hemoglobin A1C (HbA1C) in diagnosing diabetes in individuals with beta thalassemia trait?
What labs should be ordered for a 14-year-old African-American male with a hemoglobin A1c (HbA1c) of 6.2?
In an 11‑year‑old child with attention‑deficit/hyperactivity disorder treated with methylphenidate and guanfacine extended‑release, who experiences weekly prolonged outbursts when asked to comply, quarterly violent episodes, brief amnesia after each episode, no trauma history, and a recent increase of sertraline to 75 mg, what are the differential diagnoses and recommended next steps?
In a patient with inflammatory bowel disease presenting with bloody, mucoid discharge and mild-to-moderate disease activity, which inflammatory marker—C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR)—is more useful for assessing current activity?
What is the appropriate management for a patient with influenza A presenting with worsening shortness of breath and hypoxemia?
How should we manage a child with ADHD on methylphenidate and guanfacine XR, recently increased sertraline to 75 mg, who experiences severe demand‑triggered outbursts, quarterly violent episodes, and post‑episode amnesia?
What is the recommended first‑line management protocol for an adult patient with moderate‑to‑severe acute respiratory distress syndrome (PaO₂/FiO₂ ≤150 mm Hg)?
What is the recommended management for an intertrochanteric hip fracture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.